Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

International Journal of Obesity

Volumn 21, Issue 5, 1997, Pages 387-392

  Naslund E ^a   Gryback P ^b   Hellstrom P M ^b   Jacobsson, H ^b   Holst, J J ^c   Theodorsson, E ^d   Backman, L ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cholecystokinin; Gastric emptying; Glucagon like peptide 1; Intestinal bypass; Motilin; Neurotensin; Peptide YY

Indexed keywords

CHOLECYSTOKININ; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; MOTILIN; NEUROTENSIN; OXYNTOMODULIN; PEPTIDE YY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GASTROINTESTINAL MOTILITY; HUMAN; ILEUM; JEJUNOILEAL BYPASS; MALE; OBESITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STOMACH EMPTYING;

EID: 0030890568     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800418     Document Type: Article

References (31)

1. Besterman H, Sarson D, Blackburn A, Cleary J, Pilkington R, Bloom S. The gut hormone profile in morbid obesity and following jejunoileal bypass. Scand J Gastroenterol 1978; 13 (suppl. 49): 15 (abstr).
2. Sarson D, Scopinaro N, Bloom S. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity, Int J Obes 1981; 5: 471-480.
3. Sørensen T, Toftdahl D, Højgaard L, Cantor P, Klein H, Andersen B. Plama cholecystokinin in obese subjects before and after jejunoileal bypass with 3:1 or 1:3 ratio - no role in the risk of gallstone formation. Dan Med Bull 1994; 41: 469-471.
4. Sørensen T, Laurtisen KB, Holst JJ, Stadil F, Andersen B. Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. Digestion 1983; 26: 137-145.
5. Holst JJ, Sørensen T, Andersen AN, Stadil F, Andersen B, Laurtisen KB, Klein HC. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. Scand J Gastroent 1979; 14: 205-207.
6. Read NW, McFarlane A, Kinsman RI, Bates TE, Blackhall NW, Farrar CBJ, Welch I, Lee Y, Bloom SR. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984; 86: 274-280.
7. Thono H, Sarr M, DiMagio E. Intraileal carbohydrate regulates canine postprandial pancreaticobiliary secretion and upper gut motility. Gastroenterology 1995; 109: 1977-1985.
8. Welch I, Sepple C, Read N. Comparisons of the effect of infusion of lipid into the jejunoileal and ileum on eating behaviour and satiety in man. Gut 1996; 29: 857-863.
9. Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S. Glucagon-like peptide 1 enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Diabetes Care 1996; 19: 857-863.
10. Spiller R, Adrian T, Bloom S, Misiewicz J, Silk D. Further characterization of the 'ileal break' reflex in man-effect of ileal infusion of partial digests of fat, protein, and strach on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 1988; 29: 1042-1051.
11. Payne J, DeWind L. Surgical treatment of obesity. Am J Surg 1969; 118: 141-147.
12. Scott HW, Sandstead HH, Brill AB, Burko H, Younger RK. Experience with a new technique of intestinal bypass in the treatment of obesity. Ann Surg 1971; 174: 560-572.
13. Eriksson F. Bileointestinal bypass, Int J Obes 1981; 5: 437-447.
14. Theodorsson-Norheim E, Rosell S. Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion. Rep Pept 1983; 6: 207-218.
15. Ørskov C, Rabenhøj L, Kofod H, Wettergren A, Holst JJ. Production and sectretion and amidaded and glycine-extended glucagon-like peptide-1 (GLP-1) in man. Diabetes 1994; 43: 535-539.
16. Holst JJ, Bersani M. Assays for peptide products of somatostatin gen expression. In: Conn PM (ed). Methods in Neurosciences, vol. 5: Neuropeptide Technology. Academic Press: Dan Diego, 1991 pp 3-22.
17. Grybäck P, Näslund E, Hellström PM, Jacobsson H, Backman L. Gastric emptying of solids in humans: improved evaluation by Kaplan-Meier plots with special reference to obesity and gender. Eur J Nucl Med 1996; 23: 1562-1567.
18. Fenyö G, Backman L, Hallberg D. Morphology changes of the small intestine following jejuo-ileal shunt in obese subjects. Acta Chir Scand 1976; 142: 154-159.
19. Owen DA, Montessori GA, Dykstra RPJ. Jejunoileal bypass and extreme adaptive mucosal hyperplasia. Histopathology 1992; 20: 450-451.
20. Albert V, Young GP. Differentiation status of rat enterolcytes after intestinal adaption to jejunoileal bypass. Gut 1992; 33: 1638-1643.
21. Bloom SR, Polak JM. The hormonal pattern of intestinal adaption: a major role for enteroglucagon. Scand J Gastroenterol 1982; 17:(suppl. 74), 93-103.
22. Holst JJ. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 1994; 107: 1848-1855.
23. Buchanan AMJ, Pederson RA, Koop I, Gourlay RH, Cleator IGM. Morphological and functional alterations to a subgroup of regulatory peptides in human pancreas and intestine after jejunoileal bypass, Int J Obes 1993; 17: 109-113.
24. Walsh J. Gastointestinal hormones. In: Johnson LR (ed). Physiology of the Gastrointestinal Tract, 2nd edn. Raven Press: New York, 1987 pp 181-252.
25. Deacon CF, Johnsen AH, Holst JJ. Degradation of glucagon-like peptide-1 by human plasma invitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endoclinol Metab 1995; 80: 952-957.
26. Wen J, Philips SF, Sarr MG, Kost LJ, Holst JJ. PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon. Am J Physiol (Gastrointest Liver Physiol 32) 1995; 269: G945-G952.
27. Brown NJ, Rumsey RDE, Read NW. Gastrointestinal adaption to enhanced small intestinal exposure. Gut 1994; 35: 1409-1412.
28. Bray G, Barry R, Benfield J, Bray GA, Barry RE, Benfeld JR, Castelnuovo-Tedesco P, Rodin J. Intestinal bypass surgery for obesity decreases food intake and tast preferance. Am J Clin Nutr 1976; 29: 779-783.
29. Robinson RG, Folstein MF, McHugh PR. Reduced calorie intake following small bowel bypass surgery: a systemic study of possible causes. Psychol Med 1979; 9: 37-53.
30. Read N, French S, Cunningham K. The role of the gut in regulating food intake in man. Nutr Rev 1994; 52: 1-10.
31. Morely J. Appetite regulation: the role of peptides and hormones. J Endocrinol Invest 1989; 12: 135-147.